House Bill 7674
116th Congress(2019-2020)
COVID–19 Data Transparency Act
Introduced
Introduced in House on Jul 20, 2020
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
7674
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Don Beyer
grade
Virginia
Alabama
Arizona
California
California
California
California
California
California
California
California
California
Colorado
Florida
Hawaii
Illinois
Illinois
Iowa
Iowa
Maine
Massachusetts
Michigan
Minnesota
Nevada
New Jersey
New Jersey
New Jersey
New York
New York
New York
Northern Mariana Islands
Ohio
Pennsylvania
Pennsylvania
Rhode Island
Tennessee
Texas
Vermont
Virginia
Virginia
Virginia
No House votes have been held for this bill.
Summary
COVID-19 Data Transparency Act
This bill requires the Centers for Disease Control and Prevention (CDC) to standardize reporting by government health departments of COVID-19 data, including information related to hospital admissions, testing, contact tracing, and transmission rates.
In addition, the CDC must publicly post and periodically update this information on its website with individually identifiable information excluded.
July 20, 2020
07/20/2020
Referred to the House Committee on Energy and Commerce.
07/20/2020
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:45:54 PM